31 October, 2025
alta-schutte-s-aahms-fellowship-a-milestone-in-hypertension-research

Professor Alta Schutte, a prominent figure in cardiovascular research and Co-Director of the Global Cardiovascular Program at The George Institute for Global Health and UNSW Sydney, has been inducted as a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS). This prestigious recognition highlights her exceptional contributions to the field of hypertension and her influence on health policy both in Australia and globally.

Election to the AAHMS Fellowship is among Australia’s highest honors in health and medical science, celebrating individuals who have demonstrated outstanding achievement and sustained contributions in research, leadership, mentorship, and public engagement. Professor Schutte’s work exemplifies these values, particularly through her efforts in addressing global health challenges and shaping health policy.

“Our new Fellows are improving lives – from tackling global health challenges and pioneering new treatments, to shaping policy and advancing the frontiers of biomedical discovery. Their work exemplifies the Academy’s mission to advance health and medical research, promote evidence-informed policy, and foster trust in science.”

Professor Louise Baur AM PresAHMS, Academy President

Leadership in Hypertension Initiatives

In Australia, Professor Schutte serves as Co-Chair of the National Hypertension Taskforce, a multi-sectoral initiative she helped establish to combat the nation’s critically low blood pressure control rates. Under her co-leadership, the Taskforce has crafted a strategic Roadmap aiming to elevate Australia’s blood pressure control rates from 32 percent to 70 percent by 2030, thereby reducing the risk of heart disease and stroke.

Her leadership extends beyond national borders. As the senior author of the 2020 International Society of Hypertension Global Hypertension Guidelines, Professor Schutte has significantly influenced international policy. Her roles with the World Health Organisation, the Global Burden of Disease Study, and the Lancet Commission on Hypertension underscore her global impact.

Academic and Professional Achievements

Professor Schutte’s academic contributions are prolific. She has published over 550 scientific papers and has led major international research consortia. Her mentorship has guided more than 85 postgraduate students, fostering the next generation of researchers in cardiovascular health.

“It’s an honour to be elected a Fellow of the AAHMS, and I’m grateful to be recognised alongside many accomplished peers in medical science in Australia. While we’ve made real progress in improving awareness and treatment of uncontrolled hypertension, it remains one of the most significant and preventable risk factors for death and disease worldwide.”

Professor Alta Schutte

Her accolades include the 2022 Harriet Dustan Award from the American Heart Association, the 2023 Peter Sleight Excellence Award from the World Hypertension League, and the 2024 NHMRC Fiona Stanley Synergy Grant Award. These honors reflect her dedication and the global recognition of her work.

Future Directions and Global Impact

As an AAHMS Fellow, Professor Schutte joins the ranks of Australia’s most influential health and medical scientists. She is poised to continue shaping the future of cardiovascular health in Australia and worldwide. Her Fellowship provides an additional platform for collaboration with both Australian and international counterparts, enhancing the potential for significant advances in hypertension management.

Looking forward, Professor Schutte remains committed to addressing the global burden of hypertension, particularly in regions with limited access to effective and affordable treatments. Her vision includes leveraging her new role to foster international partnerships and drive forward initiatives that can make a substantial difference in global health outcomes.

Professor Schutte’s election to the AAHMS Fellowship not only honors her past achievements but also sets the stage for future contributions that could redefine cardiovascular health strategies on a global scale.